Expression of the proteasome activator PA28 rescues the presentation of a cytotoxic T lymphocyte epitope on melanoma cells
- PMID: 12019167
Expression of the proteasome activator PA28 rescues the presentation of a cytotoxic T lymphocyte epitope on melanoma cells
Abstract
The proteasome system represents a major source of HLA class I- presented peptides exposed to CTLs. Stimulation of cells with IFN-gamma instantly induces the expression of the proteasome immunosubunits as well as the proteasome activator PA28. These proteins have been shown to optimize class I antigen presentation of several viral CTL epitopes; however, their contribution to tumor antigen processing remains poorly understood. Here, we analyzed the generation of an HLA-A*0201-presented epitope derived from the melanoma antigen tyrosinase-related protein 2 (TRP2). Melanoma cells that lacked the IFN-gamma-inducible proteasome activator PA28 and immunoproteasomes did not display the TRP2(360-368) epitope to specific CTLs. Our experiments demonstrate that epitope presentation correlated with the presence of PA28 and could be completely rescued by restoration of PA28 expression. In vitro digestion of TRP2 polypeptides with 20S proteasomes confirmed that PA28 is essential for epitope liberation. Thus, our experiments indicate that PA28 provides the threshold for CTL recognition of this epitope. Importantly, processing of a second TRP2-derived epitope, TRP2(288-296), was diminished in IFN-gamma-treated cells, even in the absence of immunoproteasome up-regulation. Therefore, the reported IFN-gamma-induced self-regulation of epitopes may not necessarily be a consequence of immunoproteasomes as suggested previously.
Similar articles
-
Identification of a shared HLA-A*0201-restricted T-cell epitope from the melanoma antigen tyrosinase-related protein 2 (TRP2).Cancer Res. 1998 Nov 1;58(21):4895-901. Cancer Res. 1998. PMID: 9809996
-
Three immunoproteasome-associated subunits cooperatively generate a cytotoxic T-lymphocyte epitope of Epstein-Barr virus LMP2A by overcoming specific structures resistant to epitope liberation.J Virol. 2006 Jan;80(2):883-90. doi: 10.1128/JVI.80.2.883-890.2006. J Virol. 2006. PMID: 16378990 Free PMC article.
-
Differential influence on cytotoxic T lymphocyte epitope presentation by controlled expression of either proteasome immunosubunits or PA28.J Exp Med. 2000 Aug 21;192(4):483-94. doi: 10.1084/jem.192.4.483. J Exp Med. 2000. PMID: 10952718 Free PMC article.
-
Interferon-gamma, the functional plasticity of the ubiquitin-proteasome system, and MHC class I antigen processing.Immunol Rev. 2005 Oct;207:19-30. doi: 10.1111/j.0105-2896.2005.00308.x. Immunol Rev. 2005. PMID: 16181324 Review.
-
The role of the proteasome system and the proteasome activator PA28 complex in the cellular immune response.Biol Chem. 1999 Mar;380(3):293-7. doi: 10.1515/BC.1999.040. Biol Chem. 1999. PMID: 10223331 Review.
Cited by
-
The FAT10- and ubiquitin-dependent degradation machineries exhibit common and distinct requirements for MHC class I antigen presentation.Cell Mol Life Sci. 2012 Jul;69(14):2443-54. doi: 10.1007/s00018-012-0933-5. Epub 2012 Feb 19. Cell Mol Life Sci. 2012. PMID: 22349260 Free PMC article.
-
Current strategies in engaging oncolytic viruses with antitumor immunity.Mol Ther Oncolytics. 2021 May 14;22:98-113. doi: 10.1016/j.omto.2021.05.002. eCollection 2021 Sep 24. Mol Ther Oncolytics. 2021. PMID: 34514092 Free PMC article. Review.
-
The Role of the Proteasome in Platelet Function.Int J Mol Sci. 2021 Apr 13;22(8):3999. doi: 10.3390/ijms22083999. Int J Mol Sci. 2021. PMID: 33924425 Free PMC article. Review.
-
Proteasomes and Several Aspects of Their Heterogeneity Relevant to Cancer.Front Oncol. 2019 Aug 13;9:761. doi: 10.3389/fonc.2019.00761. eCollection 2019. Front Oncol. 2019. PMID: 31456945 Free PMC article. Review.
-
The ubiquitin-proteasome system and microvascular complications of diabetes.J Ophthalmic Vis Res. 2013 Jul;8(3):244-56. J Ophthalmic Vis Res. 2013. PMID: 24349668 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials
Miscellaneous